News
New analysis shows promising repigmentation with JAK inhibitors in vitiligo, especially in combination with UVB. Safety and ...
Though not yet approved, investors are already eyeing the drug as a potential blockbuster. Its commercial rights holder in ...
4d
Sinar Daily on MSNVitiligo A Non-contagious, Harmless Skin Condition, Says Expertbout seven years ago, Farah (not her real name) found some white spots appearing on the left side of her face. At first, she dismissed it as a simple fungal infection. But as the weeks passed, the ...
Results in vitiligo came from the TRuE-V1 and TRuE-V2 studies, which showed that around 30% of patients treated with ruxolitinib cream twice daily achieved 75% or more improvement from baseline in ...
The FDA has approved Incyte's Opzelura cream for atopic dermatitis ... pick up an additional indication as a treatment for skin pigmentation disease vitiligo. Its approval for atopic dermatitis ...
Almirall - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into the Almirall's tech activities, including its digital transformation strategies, ...
I'm only 34, and refuse to look old before my time. In recent times I've heard of various treatments for vitiligo. Steroid creams can be used for a limited period and may restore some colour.
Clascoterone cream 1% used twice daily for 2 ... improved the efficacy of ritlecitinib for the treatment of patients with nonsegmental vitiligo, according to a study.
Incyte reports better-than-expected first-quarter 2025 results, beating both earnings and revenue estimates, driven by strong Jakafi and Opzelura sales.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results